Key Insights

Highlights

Success Rate

100% trial completion (above average)

Published Results

14 trials with published results (23%)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

0.0%

0 terminated out of 62 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

16%

10 trials in Phase 3/4

Results Transparency

41%

14 of 34 completed with results

Key Signals

14 with results100% success

Data Visualizations

Phase Distribution

56Total
Not Applicable (20)
Early P 1 (1)
P 1 (5)
P 2 (20)
P 3 (6)
P 4 (4)

Trial Status

Completed34
Unknown11
Recruiting9
Not Yet Recruiting3
Withdrawn2
Active Not Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 34 completed trials

Clinical Trials (62)

Showing 20 of 20 trials
NCT07775313Phase 1Enrolling By Invitation

Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM

NCT00867269Recruiting

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

NCT07848100Phase 3Not Yet RecruitingPrimary

Intralesional Acyclovir Versus Intralesional Zinc Sulphate in the Treatment of Plantar Warts

NCT00967785Phase 1Completed

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

NCT07806617Phase 2Active Not RecruitingPrimary

Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts

NCT07637734Phase 3Recruiting

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)

NCT06812065Not ApplicableRecruitingPrimary

Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts

NCT07329907Phase 2CompletedPrimary

Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic

NCT02231879Phase 2Completed

Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome

NCT07457918Phase 3Recruiting

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

NCT07534865Not ApplicableRecruitingPrimary

Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts

NCT07396714Early Phase 1Not Yet RecruitingPrimary

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

NCT07246590Phase 3Recruiting

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

NCT05087849Phase 1Completed

Intralesional HPV Vaccine for Condylomata

NCT06827938Not ApplicableRecruitingPrimary

Multicenter Real-World Study of Hyperthermia in Warts of Special Population

NCT05291845Phase 2RecruitingPrimary

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts

NCT06973473Not Yet RecruitingPrimary

Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.

NCT05799157Phase 2Completed

Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts

NCT00472459Phase 3Completed

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

NCT06214559Not ApplicableCompletedPrimary

Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts.

Scroll to load more

Research Network

Activity Timeline